Cargando…
Toward Precision Medicine with Human Pluripotent Stem Cells for Diabetes
Although genome profiling provides important genetic and phenotypic details for applying precision medicine to diabetes, it is imperative to integrate in vitro human cell models, accurately recapitulating the genetic alterations associated with diabetes. The absence of the appropriate preclinical hu...
Autores principales: | Memon, Bushra, Abdelalim, Essam M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299517/ https://www.ncbi.nlm.nih.gov/pubmed/35640144 http://dx.doi.org/10.1093/stcltm/szac030 |
Ejemplares similares
-
Stem Cell Therapy for Diabetes: Beta Cells versus Pancreatic Progenitors
por: Memon, Bushra, et al.
Publicado: (2020) -
Human Induced Pluripotent Stem Cells: From Cell Origin, Genomic Stability, and Epigenetic Memory to Translational Medicine
por: Poetsch, Mareike S, et al.
Publicado: (2022) -
Neuronal cell‐based medicines from pluripotent stem cells: Development, production, and preclinical assessment
por: Sun, Yun, et al.
Publicado: (2021) -
Differentiation of human pluripotent stem cells into two distinct NKX6.1 populations of pancreatic progenitors
por: Aigha, Idil I., et al.
Publicado: (2018) -
Enhanced differentiation of human pluripotent stem cells into pancreatic progenitors co-expressing PDX1 and NKX6.1
por: Memon, Bushra, et al.
Publicado: (2018)